SOURCE: Imprivata

Imprivata

February 23, 2010 09:00 ET

Dr. Barry P. Chaiken Joins Imprivata as Chief Medical Officer

Recognized Expert in Clinician Adoption of Information Technology and Patient Safety Brings Over 20 Years of Experience to the Healthcare Division

LEXINGTON, MA--(Marketwire - February 23, 2010) -  Imprivata®, Inc., the company that simplifies and secures user access, today announced the appointment of Barry P. Chaiken, MD, MPH, FHIMSS as the company's chief medical officer (CMO). In this role, Dr. Chaiken will lend his considerable expertise to Imprivata's new Global Healthcare Division, advising on product direction and driving strategic healthcare relationships and partnerships. 

"Dr. Chaiken's diverse expertise, strategic thinking and global perspective add tremendous value to our team," said Omar Hussain, president and CEO of Imprivata. "His experience as a clinician, author, professor, and current HIMSS chair provide him with unique insight, and we are delighted that we are able to tap into that knowledge and apply his sound perspective to help drive the success of our healthcare division."

Dr. Chaiken has more than 20 years of experience in healthcare information technology, patient safety, clinical transformation, and public health, with extensive expertise in helping healthcare organizations utilize information technology to improve clinical and administrative activities. He is board certified in General Preventative Medicine and Public Health, as well as Healthcare Quality Management, and is currently a fellow and serving as 2009-2010 Board Chair of the Health Information Management and Systems Society (HIMSS). He has worked on quality improvement studies and clinical investigations for the National Institutes of Health, U.K.'s National Health Service and Boston University Medical School.

"The deployment of practical solutions to ensure the privacy and security of electronic medical records (EMRs), without crippling workflow, is critical to the widespread adoption of EMRs by the public, and ultimately to the overall goal of improved patient outcomes," said Barry P. Chaiken, chief medical officer of Imprivata. "Imprivata's technology and market leadership are evidence of its deep understanding of clinician workflows and the nuances of healthcare environments. I'm excited to join the team and address the unique user access and security challenges healthcare organizations face."

Dr. Chaiken additionally serves as the chief medical officer at DocsNetwork, Ltd., where he provides thought leadership and offers clients his expertise in clinical transformation and quality improvement. He received his medical degree from SUNY Downstate Medical Center, NYC, his masters in public health degree in health services administration from Harvard School of Public Health and his bachelor of arts degree in psychology from the University of Albany. Dr. Chaiken acquired his specialty training from the Centers for Disease Control as an Epidemic Intelligence Service officer and from the New Jersey State Department of Health as a preventative medicine resident. He also holds an appointment as Adjunct Assistant Professor in the Department of Public Health and Family Medicine at Tufts University School of Medicine. 

For people interested in meeting with the Imprivata team at HIMSS, please contact imprivata@famapr.com. Additionally, for live updates from HIMSS, please follow Imprivata on Twitter at www.twitter.com/imprivata.

About Imprivata
Imprivata is the leading independent vendor focused on simplifying and securing user access. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments, customers can align security with user's workflows and realize substantial productivity gains while lowering IT costs.

Imprivata has received numerous product awards and top review ratings from leading industry publications and analysts. Headquartered in Lexington, Mass., Imprivata partners with over 200 resellers, and serves the access security needs of more than 900 customers around the world. For more information, please visit www.imprivata.com.

Imprivata is a registered trademark of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

RSS Feed to Imprivata News: http://feeds.feedburner.com/ImprivataNews

Follow Imprivata on Twitter: https://twitter.com/Imprivata

Contact Information

Webosphere

Keyword Cloud

View Website